ATE332711T1 - Eine neue komponente des 'hedgehog'- signalübertragungsweges - Google Patents
Eine neue komponente des 'hedgehog'- signalübertragungswegesInfo
- Publication number
- ATE332711T1 ATE332711T1 AT99956430T AT99956430T ATE332711T1 AT E332711 T1 ATE332711 T1 AT E332711T1 AT 99956430 T AT99956430 T AT 99956430T AT 99956430 T AT99956430 T AT 99956430T AT E332711 T1 ATE332711 T1 AT E332711T1
- Authority
- AT
- Austria
- Prior art keywords
- ptch2
- hedgehog
- signal transmission
- transmission path
- new component
- Prior art date
Links
- 241000027355 Ferocactus setispinus Species 0.000 title 1
- 230000008054 signal transmission Effects 0.000 title 1
- 102000003693 Hedgehog Proteins Human genes 0.000 abstract 2
- 108090000031 Hedgehog Proteins Proteins 0.000 abstract 2
- 108020004999 messenger RNA Proteins 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 108700024394 Exon Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Cable Transmission Systems, Equalization Of Radio And Reduction Of Echo (AREA)
- Reduction Or Emphasis Of Bandwidth Of Signals (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9803393A SE9803393D0 (sv) | 1998-10-06 | 1998-10-06 | A novel component in the hedgehog signalling pathway |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE332711T1 true ATE332711T1 (de) | 2006-08-15 |
Family
ID=20412843
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99956430T ATE332711T1 (de) | 1998-10-06 | 1999-10-06 | Eine neue komponente des 'hedgehog'- signalübertragungsweges |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US6881833B1 (de) |
| EP (1) | EP1121157B1 (de) |
| JP (1) | JP2002526050A (de) |
| AT (1) | ATE332711T1 (de) |
| AU (1) | AU1304400A (de) |
| DE (1) | DE69932340T2 (de) |
| ES (1) | ES2268886T3 (de) |
| SE (1) | SE9803393D0 (de) |
| WO (1) | WO2000020037A1 (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6709838B1 (en) * | 1998-04-15 | 2004-03-23 | Genentech, Inc. | Nucleic acid encoding patched-2 |
| WO2002046403A2 (en) * | 2000-12-05 | 2002-06-13 | Bayer Aktiengesellschaft | Regulation of human patched-like protein |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6027882A (en) | 1994-10-07 | 2000-02-22 | The Regents Of The University Of California | Patched genes and their use for diagnostics |
| EP0879888A3 (de) * | 1997-05-23 | 1999-07-14 | Smithkline Beecham Plc | Patched-2 Polypeptide und Polynucleotide und Methoden zu ihrer Herstellung |
| EP1037982A1 (de) * | 1997-12-08 | 2000-09-27 | Ontogeny, Inc. | Menschliche patched gene und proteine, und entsprechende verwendungen |
| US6709838B1 (en) * | 1998-04-15 | 2004-03-23 | Genentech, Inc. | Nucleic acid encoding patched-2 |
| US6348575B1 (en) * | 1998-04-15 | 2002-02-19 | Genentech, Inc. | Patched-2 |
-
1998
- 1998-10-06 SE SE9803393A patent/SE9803393D0/xx unknown
-
1999
- 1999-10-06 WO PCT/SE1999/001784 patent/WO2000020037A1/en not_active Ceased
- 1999-10-06 DE DE69932340T patent/DE69932340T2/de not_active Expired - Fee Related
- 1999-10-06 US US09/807,007 patent/US6881833B1/en not_active Expired - Fee Related
- 1999-10-06 JP JP2000573395A patent/JP2002526050A/ja not_active Withdrawn
- 1999-10-06 ES ES99956430T patent/ES2268886T3/es not_active Expired - Lifetime
- 1999-10-06 AU AU13044/00A patent/AU1304400A/en not_active Abandoned
- 1999-10-06 EP EP99956430A patent/EP1121157B1/de not_active Expired - Lifetime
- 1999-10-06 AT AT99956430T patent/ATE332711T1/de not_active IP Right Cessation
-
2004
- 2004-03-04 US US10/791,844 patent/US20040146929A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP1121157B1 (de) | 2006-07-12 |
| SE9803393D0 (sv) | 1998-10-06 |
| ES2268886T3 (es) | 2007-03-16 |
| WO2000020037A1 (en) | 2000-04-13 |
| EP1121157A1 (de) | 2001-08-08 |
| US20040146929A1 (en) | 2004-07-29 |
| DE69932340T2 (de) | 2007-07-26 |
| AU1304400A (en) | 2000-04-26 |
| DE69932340D1 (de) | 2006-08-24 |
| JP2002526050A (ja) | 2002-08-20 |
| US6881833B1 (en) | 2005-04-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2001062280A3 (en) | Lipase-containing composition and methods of use thereof | |
| WO2002024909A3 (en) | Receptor nucleic acids and polypeptides | |
| WO1999014346A3 (en) | SENSE mRNA THERAPY | |
| ATE484587T1 (de) | Ldcam genannte moleküle | |
| ATE297188T1 (de) | Stabilisierte ascorbinsäure-lösungen | |
| WO2002014485A3 (en) | Kallikrein gene | |
| WO2003048205A3 (fr) | Proteines a activite inhibitrice de l'il-6 | |
| AU7303301A (en) | Isolated nucleic acid molecules which encode t cell inducible factors, or interleukin-21, the proteins encoded, and uses thereof | |
| WO1998011234A3 (en) | Human protein kinases | |
| DK0793721T3 (da) | Peptider, der er i stand til at binde sig til GAP-proteinets SH3-domæne, nukleotidsekvenser, der koder derfor, fremstilling og anvendelse deraf | |
| WO2002049625A3 (en) | Compounds that affect cd83 expression, pharmaceutical compositions comprising said compounds and methods for identifying said compounds | |
| DE69932340D1 (de) | Eine neue komponente des 'hedgehog'-signalübertragungsweges | |
| BR9711540A (pt) | Inibidores de protease proteìnico estabilizados e variantes dos mesmos | |
| WO2002022661A3 (en) | NOVEL PDEs AND USES THEREOF | |
| EP1151089A4 (de) | Katalytische moleküle | |
| DK0939769T3 (da) | Vertebrat-Smoothened-proteiner | |
| WO2001059120A3 (en) | Il-17 like molecules and uses thereof | |
| WO2001036626A3 (en) | Pentraxin i and pentraxin receptor, inhibitors of said proteins and pharmaceutical compositions containing said compounds | |
| DE69812438D1 (de) | Zusammensetzung zur herstellung von brennstoff-briketts | |
| WO1999002724A3 (en) | Methods for identifying genes expressed in selected lineages, and a novel genes identified using the methods | |
| WO2002024727A3 (en) | New inhibitors of iapp fibril formation and uses thereof | |
| WO1997046673A3 (en) | Inhibition of hiv-1 replication by antisense rna expression | |
| EP1097999A3 (de) | An das durch Abscisinsäure-aktivierbare-Element bindende Transkriptionsfaktoren | |
| DE60104789D1 (de) | Verfahren zur Herstellung von 2,4,5-Trialkylbenzaldehyden | |
| DE60004931D1 (de) | Kontinuierliches Verfahren zur Herstellung von 3,5,5-Trimethylcyclohexa-3-en-1-on(beta-Isophoron) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |